Combined high-dose delta1-testololactone with low-dose 5-fluorouracil in the treatment of metastatic breast cancer.
D001772:Blood Cell Count; D001792:Blood Platelets; D001943:Breast Neoplasms / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005069:Evaluation Studies as Topic; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006413:Hematopoietic System / Q000187:drug effects; D006801:Humans; D007958:Leukocyte Count; D008875:Middle Aged; D009362:Neoplasm Metastasis; D013738:Testolactone / Q000008:administration & dosage / Q000627:therapeutic use*
D013738:Testolactone; D005472:Fluorouracil